Lastra Ricardo R, Ou Joyce J, Reilly Mary E, Lawrence W Dwayne, Baloch Zubair W, Brooks John S, Barroeta Julieta E
Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Diagn Cytopathol. 2014 May;42(5):375-9. doi: 10.1002/dc.23029. Epub 2013 Aug 1.
The diagnosis of atypical glandular cells of undetermined significance (AGUS) in liquid-based cervical cytology specimens shows significant underlying pathology in only 30% of cases, while the remaining cases are found to be benign (reactive, reparative/metaplastic). Previous studies have reported positive ProExC and IMP3 staining in neoplastic glandular lesions of the uterine cervix and corpus. We present our experience with the utility of these markers in the evaluation of AGUS cases in liquid-based cervical cytology. The case cohort included 34 cases diagnosed as AGUS. ProExC and IMP3 immunocytochemical (ICC) stains were performed on ThinPrep® slides and the results correlated with subsequent biopsy findings. Positive expression was classified as strong diffuse nuclear immunostaining for ProExC and granular cytoplasmic for IMP3. The presence of AGUS cells on the ICC stained slides was confirmed in all cases. IMP3 was positive in 80% of glandular neoplasms and negative in 93% non-glandular lesions/cases negative for squamous intraepithelial lesion (SIL). ProExC was positive in 60% of glandular neoplasms and negative in 83% non-glandular lesions/cases negative for SIL. When used as a panel (ProExC + IMP3), at least one stain was positive in 100% of glandular neoplasm cases and they were both negative in 83% of non-glandular lesions/cases negative for SIL. Based on this study, both ProExC and IMP3, when used as an immuno panel, can predict the presence of glandular lesions on subsequent biopsies and can serve as an aid in the diagnosis and management of AGUS cases.
在液基宫颈细胞学标本中,意义不明确的非典型腺细胞(AGUS)诊断仅在30%的病例中显示有显著的潜在病理学改变,而其余病例被发现为良性(反应性、修复性/化生)。既往研究报道,ProExC和IMP3染色在子宫颈和子宫体的肿瘤性腺性病变中呈阳性。我们介绍了这些标志物在评估液基宫颈细胞学AGUS病例中的应用经验。病例队列包括34例诊断为AGUS的病例。在ThinPrep®玻片上进行ProExC和IMP3免疫细胞化学(ICC)染色,并将结果与随后的活检结果相关联。阳性表达分类为ProExC的强弥漫性核免疫染色和IMP3的颗粒状细胞质染色。所有病例在ICC染色玻片上均证实存在AGUS细胞。IMP3在80%的腺性肿瘤中呈阳性,在93%的非腺性病变/鳞状上皮内病变(SIL)阴性病例中呈阴性。ProExC在60%的腺性肿瘤中呈阳性,在83%的非腺性病变/SIL阴性病例中呈阴性。当作为一组指标(ProExC + IMP3)使用时,100%的腺性肿瘤病例中至少有一种染色呈阳性,而在83%的非腺性病变/SIL阴性病例中两者均为阴性。基于本研究,ProExC和IMP3作为免疫组化指标使用时,均可预测随后活检中腺性病变的存在,并有助于AGUS病例的诊断和管理